Metagenomi Therapeutics MGX SEC Filings

NASDAQ MGX
$1.17 +0.02 (+1.74%)
As of: Sep 10, 2026 · 2:05 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Metagenomi Therapeutics, Inc. (MGX) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index